Recent Updates
Recently added Catalysts
TVTX Positive Sentiment

Travere Therapeutics to Participate at Upcoming Investor Conferences

Wednesday, August 5, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Travere Therapeutics, Inc. has announced its participation in several upcoming investor conferences, including Canaccord Genuity's Annual Growth Conference and the Wells Fargo Healthcare Conference. These events are scheduled for August and September 2026. The company's management aims to engage with investors and discuss future prospects.
Price reaction · baseline $62.76 (2026-08-05 close) · hit after-hours · clean, no other TVTX news in the window
day 0 close
-0.5%

Market Sentiment Analysis

POSITIVE FACTORS

  • Travere Therapeutics is actively engaging with investors.
  • Participation in multiple conferences indicates strong company visibility.
  • Management's presence at these events may enhance investor confidence.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+68%
120-day peak, hindsight
Typical move
8.6%
average across 10 past catalysts
Lead asset
Sparsentan
Phase 2 · ANCA Associated Vasculitis

Full Press Release Details

SAN DIEGO--(BUSINESS WIRE)--Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced that company management will participate in the following upcoming investor conferences: Canaccord Genuity's 46th Annual Growth Conference Presenting on Tuesday, August 11, 2026, at 3:00 p.m. ET Wells Fargo 21st Annual Healthcare Conference Tuesday, September 8, 2026 Citi 2026 Biopharma Back to School Conference Wednesday, September 9, 2026 2026 Cantor Global Healthcare Conference Presenting on Thursday, Septe

Frequently Asked Questions

What conferences will Travere Therapeutics attend?

Travere Therapeutics will attend the Canaccord Genuity Annual Growth Conference, Wells Fargo Healthcare Conference, and Citi Biopharma Back to School Conference.

When is Travere's presentation at the Canaccord conference?

Travere will present at the Canaccord Genuity's 46th Annual Growth Conference on August 11, 2026.

What is the purpose of these conferences for Travere?

The conferences aim to engage with investors and discuss the company's future prospects.

ShareAdd on Google
Tags: TVTX Travere Therapeutics investor conferences healthcare conference biopharma events
Last updated: Aug 5, 2026

Biotech snapshot

Cash runway
$489M liquidity · $0M/mo burn
Low dilution risk
Lead asset
SparsentanPhase 2
ANCA Associated Vasculitis →

Catalyst track record

+68%
best trade around TVTX's most recent catalyst

Peak hindsight return over a 120-day window, across 10 tracked FDA/PDUFA catalysts for TVTX.

See every catalyst's timing & PoA →